Antineoplastic agents for pediatric anaplastic large cell lymphoma: Vinblastine is the most effective in vitro

Leukemia and Lymphoma

Volumn 46, Issue 10, 2005, Pages 1489-1496

  Muto, Akiko ^a   Nakagawa, Atsuko ^b   Shimomura, Yasuhito ^a   Kitagawa, Yoshiro ^a   Tsurusawa, Masahito ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Anaplastic large cell lymphoma; Chemotherapy; MTT assay; Vinblastine

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 HYDROPEROXYCYCLOPHOSPHAMIDE; 4 HYDROPEROXYIFOSFAMIDE; ANTINEOPLASTIC AGENT; CISPLATIN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISOLONE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CHILDHOOD CANCER; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IN VITRO STUDY; LARGE CELL LYMPHOMA; LYMPHOMA CELL LINE; MALE; MITOSIS SPINDLE; PRIORITY JOURNAL; SCHOOL CHILD;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; LYMPHOMA, LARGE-CELL, KI-1; TUBULIN; VINBLASTINE;

EID: 26944466420     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500126547     Document Type: Article

References (16)

1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplasmtic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985;66:848-858.
2. Delsol G, Rallfkiaer E, Stein H, Wright D, Jaffe ES. Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. pp 230-235.
3. Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, et al. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 1994;12:899-908
4. Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, et al. Short-pulse B-nonHodgkin Lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt - Munster Group Trial NHL-BFM 90. Blood 2001;97:3699-3706.
5. Brugieres L, Le Deley MC, Pacquement H, Meguerian-Bedoyan Z, Terrier-Lacombe MJ, et al. CD30anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French society of pediatric oncology. Blood 1998;92:3591-3598.
6. Williams DM, Hobson R, Imeson J, Gerrard M, McCarthy K, Pinkerton CR. Anaplastic large cell lymphoma in childhood: analysis of 72 patient treated on United Kingdom Children's Cancer Study Group chemotherapy regimens. Br J Haematol 2002;117:812-820.
7. Massimino M, Gasparini M, Giardini R. Ki-1 (CD30) anaplastic large-cell lymphoma in children. Ann Oncol 1995;6:915-920
8. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994;263:1281-1284.
9. Falini B, Pileri S, Zinzani PL, Carbone A, Zagonel V, Wolf-Peeters C, et al. ALK + Lymphoma: Clinicopathological findings and outcome. Blood 1999;93:2697-2706.
10. Drexler HG. The leukemia-lymphoma cell line facts book. London: Academic Press; 2000.
11. Drexler HG, MacLeod RAF. Malignant hematopoietic cell lines. In vitro models for the study of anaplastic large-cell lymphoma. Leukemia 2004;18:1569-1571.
12. Drexler HG, Gignac SM, Dirks WG, von Wasielewski R, Werner M. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia 2000;14:1533-1559.
13. Chen CL, Fuscoe JC, Liu Q, Pui C-H. Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide. J Natl Cancer Inst 1996;88:1840-1847.
14. Hijiya N, Gajjar A, Zhang Z, Sandlund JT, Ribeiro RC, Rubnitz JE, et al. Low-dose oral etoposide-based induction regimen for children with acute lymphoblastic leukemia in first bone marrow relapse. Leukemia 2004;18:1581-1586.
15. 2-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine. Cancer Res 2001;61:4450-4458.
16. Brugieres L, Quartier P, Le Delay MC, Pacquement H, Perel Y, Bergeron C, et al. Relapse of childhood anaplastic large-cell lymphoma: Treatment results in a series of 41 children-a report from the French Society of Pediatric Oncology. Ann Oncol 2000;11:53-58.